Methods for the estimation of the effects of chronic disease risk factors on mortality continue to be an area that generates confusion and controversy. In response to the frequently observed U-or J-shaped relations between risk factors and mortality, some authors suggest that subjects dying during the first k years of follow-up (where k is some positive number less than the total length of follow-up) be excluded from statistical analyses. By excluded, the authors mean completely removed from the data set. The rationale is that persons dying during the first k years are likely to have a preexisting occult disease that confounds the relation between the risk factor under study and mortality. Excluding persons dying during the first k years of follow-up purportedly reduces this confounding. However, the authors are aware of no demonstration that this procedure effectively accomplishes its goal. They show that excluding subjects who die during the first k years of follow-up does not necessarily lead to a reduction in bias in the estimated effect of a risk factor on mortality when this relation is confounded by the presence of occult disease. Moreover, it is possible for such exclusion to exacerbate the confounding due to preexisting disease. Thus, excluding subjects dying during the first k years of follow-up is not necessarily an effective strategy for dealing with confounding due to occult disease. Investigators are encouraged to pursue alternative methods. Am J Epidemiol 1997; 146:672-80. cohort studies; confounding factors (epidemiology); death; mortality; odds ratio; relative hazard; relative risk Many variables such as adiposity, blood pressure, serum lipid levels, and serum glucose levels are thought to influence longevity. Unfortunately, it is generally not possible to conduct randomized experiments to evaluate the causal influences of such variables on longevity. Instead, investigators typically turn to prospective cohort studies. In the prototypical studies, N individuals have their baseline value of the putative risk factor of interest measured at the start of follow-up and are then followed until time t. Whether or not death occurred and, in some cases, time of death are recorded for each subject. The association between levels of the risk factor and mortality is then evaluated with one of a number of procedures (1, 2). In some cases the variable is kept in continuous form, and logistic regression (3, 4) or some form of survival
Many variables such as adiposity, blood pressure, serum lipid levels, and serum glucose levels are thought to influence longevity. Unfortunately, it is generally not possible to conduct randomized experiments to evaluate the causal influences of such variables on longevity. Instead, investigators typically turn to prospective cohort studies. In the prototypical studies, N individuals have their baseline value of the putative risk factor of interest measured at the start of follow-up and are then followed until time t. Whether or not death occurred and, in some cases, time of death are recorded for each subject. The association between levels of the risk factor and mortality is then evaluated with one of a number of procedures (1, 2) . In some cases the variable is kept in continuous form, and logistic regression (3, 4) or some form of survival analysis (5-11) is used to evaluate the "effect" of the risk factor on mortality. In many other cases, the independent variable is divided into quantiles. When quantiles are used, calculating relative risks in the quantiles becomes an additional analytic option some investigators choose (1, 2) .
When such analyses are conducted, a common finding is that there is a U-or /-shaped relation between the putative risk factor and mortality. That is, subjects with very high and very low values of the risk factor tend to die sooner than subjects with more intermediate levels of the risk factor. This often seems counterintuitive to investigators (12) . In response, investigators have suggested that the elevation of risk at the low end of the continuum may be due to confounding due to preexisting unobserved or "occult" disease. That is, the risk factor level may be low because the subject has an occult disease that causes reductions in the risk factor and because the occult disease causes increases in mortality.
Regarding the definition of confounding, in the present context by confounding we mean that the disease affects the risk factor and that the disease independently affects mortality. Of course, many other and more complex models are possible (13) . For example, in reality it seems quite plausible that there is some reciprocal causation between the disease and the risk factor level. That is, in some cases disease causes reductions in a risk factor and, in addition, elevations in the risk factor may cause disease that in turn causes mortality. For example, high values of body mass index seem to predispose individuals toward an increased probability of certain forms of cancer (14, 15) . However, once an individual develops cancer, cancer seems to frequently result in weight loss (16) (17) (18) . Under such situations, the meaning of the effect of risk independent of disease is more complex (13) . We restrict our attention to the classic case of confounding in which the confounder (in this case, occult disease) is not an intermediate variable in the path from the risk factor to mortality. This confounding cannot be eliminated by including occult disease status as a covariate because occult disease is, by definition, unobservable.
As an alternative to including occult disease as a covariate, it has been suggested that subjects who die during the first few (k) years be excluded from the analysis. By excluded, we mean completely removed from the data set. To our knowledge, this proposition was first articulated as a general principle by Manson et al. (19) in the context of obesity. We will refer to this exclusion as the "&-years" exclusion.
Manson et al. stated, "the failure to eliminate early mortality from the analysis ... [results] in the effects of disease on weight being evaluated in addition to the effect of weight on the development of disease" (19, p. 353) . They went on to write, "A reasonable approach to obviate the artifactually high mortality associated with lower body weight is to disregard mortality within the first few years of follow-up, based on the assumption that such deaths are largely due to disease present at entry. This restriction . .. would reduce substantially the bias due to underlying disease" (19, p. 356 ). However, they offered no evidence to support the latter assertion. Moreover, a search of the statistical literature revealed no discussion of this technique and no evidence that it necessarily will reduce confounding due to occult disease in the event that such confounding is present. In addition, there has been no guidance in the literature as to how one should select the values of k. In practice, our experience is that people select value of k ranging from 1 to 7, and the choice of k seems to be largely motivated by the availability of a sufficiently long follow-up to select a large value of k. In fact, the only discussion we found in the truly "statistical" literature remotely related to this topic is a statement by Breslow and Day (20) who said, "If the association [between risk factors and mortality] weakens steadily as the time interval increases, serious doubt would be cast on its interpretation as causal" (20, p. 44 ).
If excluding early deaths resulted in elimination of all diseased subjects and no nondiseased subjects, the bias would be eliminated. However, this outcome seems quite unlikely to be achieved, raising questions about what the results of early mortality exclusion will be, since the constitution of a resulting group depends on the baseline distribution of the putative risk factors, as well as of the occult disease, over the excluded subjects.
Nevertheless, excluding early deaths is a widely used technique. It has been used in the area of serum lipids (21, 22) , blood pressure (23, 24) , sarcopenia (25) , and physical activity (26) . It is perhaps most strongly advocated in the field of obesity. Since publication of the paper by Manson et al. (19) , several authors have described not excluding early deaths as a "failure" in the data analysis (27, 28) . The degree to which the proposition by Manson et al. has been accepted as fact is illustrated by the following quotation from a recent review on healthy body weights: "Consistent significant findings for mortality can only [emphasis added] be obtained when . . . data from the first few years are discarded to reduce the effects of undetected illnesses" (29, p. 448S).
In this paper, we show that, when confounding due to preexisting disease is present at the start of followup, excluding subjects who die in the first few years of follow-up does not necessarily reduce that confounding. Moreover, such exclusion can even exacerbate the bias in the estimate of the effect of exposure.
STATISTICAL MODELS
Assuming that the survival time T is exponentially distributed with a rate parameter A, we model A as follows:
where A o > 0; X -1 if exposed to the risk factor, = 0 otherwise; and D -1 if diseased, = 0 otherwise. /3 X is assumed to be greater than zero and smaller than /3 D , so that the risk factor is harmful but less harmful than the disease. We denote the distribution function by
the
survival function by S(t; x,d) = l -F(t; x, d), the density function by fit; x, d) = F' -dldt F{t; x, d), and the hazard function by h(t; x, d) = j{t; x, d)IS{t; x, d)
(subscripts for these functions will be attached correspondingly). Denoting the probabilities of being diseased conditional on the risk factor by p, = P(D -1|X = 1) andp 0 = P(JD = l|X = 0), we further assume m = PolPi, where m is less than 1/p, and greater than one, which implies that the nonexposed group is more prone to the disease. When there is no information about the status of disease, what we observe is the following ("confounded" by disease) distribution functions, F lc and F Oc , for the exposed and the nonexposed groups, respectively, that is:
where as the true "unconfounded" distribution functions in the nondiseased group are
and
respectively. Furthermore, if people dying in the first k years are excluded from the analysis, then what we obtain is the following ("fc-years") distribution functions, F lk and F Ok ; that is, for k < t:
and = P(T^t, o,
This modeling and these assumptions allow us to consider the extent to which the confounding effect of occult disease results in a negative bias (i.e., an underestimation) of the risk factor effect. Moreover, it allows one to see if "fc-years" exclusion will reduce such confounding.
POPULATION EFFECT SIZES AND THEIR COMPARISON
The effect of a risk factor on mortality is generally expressed with one of three effect size indicators: the relative risk or risk ratio; the odds ratio; or the hazard ratio. In each case, the quantity of interest is the effect size calculated in the nondiseased group (i.e., the unconfounded effect size). Unfortunately, investigators in the confounded situation do not have the opportunity to calculate this and instead can calculate the effect size in the confounded group. An alternative is to calculate the effect size in the "^-years" group, that is, the confounded group after eliminating subjects who die during the first &-years. Thus, the "confounded" and "k-years" effect sizes are proxies or surrogates for their "unconfounded" counterparts. The question of interest is then: "To what extent are effect sizes calculated from the &-years population better approximations of the unconfounded effect sizes than are the confounded effect sizes?" Therefore, we compare the effect sizes from the "unconfounded," "confounded," and "fc-years" distribution functions below. For a study with a follow-up until time t, we have the following relative risks or risk ratios (RRs):
Similarly, for a study with follow-up until time t, the odds ratios (ORs) are:
F Ox (t) and OR* = Finally, the hazard ratios (HRs) at time t are:
(0 /.,«« Ikuit)
and HR* = In this formulation, the deviations of both "confounded" and "fc-years" ratios can be defined with respect to the "unconfounded" ratios. If the "fc-years" approach does what it is purported to do, then the effect sizes calculated from the ")t-years" distribution should be closer to the "unconfounded" effect sizes than are those from the "confounded" distribution. That is, the "&-years" approach "works" when: IRR* -RR U < |RR C -RRJ; |OR* -ORj < |OR C -ORj; and HR* -HRj < |HR C -HRj.
It can be shown by counter examples that this is not necessarily true. Consider a set of parameters, satisfying the restrictions on them discussed previously. The scale of time is years, and the other parameters are as follows: P x = 1, /3 D = 4, p x = 0.02, m = 10, it = 3, and A o = 0.001. In this set, the occult disease is set up as extremely harmful as might be the case with some diseases, and the disease is 10 times more prevalent among the nonexposed group than the exposed group to reflect the idea of confounding toward the null for the risk factor effect. For the nonexposed and nondiseased group, the probability of dying in 1 year is virtually zero, which is reflected through the value of A o . Note that the effect sizes calculated under this set of parameters represent population characteristics, not estimates from a simulation study.
In figure 1 , risk ratios are compared. It can be seen that both RR* and RR C deviate from RR U and that for time points less than 25 years, RR fc is smaller than RR C . This implies that the deviation of RR^ from RR W is greater than that of RR C when the follow-up time is less than 25 years. For large follow-up times, the improvement is seen to be negligible.
For the same specification of parameters, similar observations can be seen for the odds ratio in figure 2 . Here again, both OR^ and OR C are seen to underestimate OR U . For time points less than 16, the deviation of OR*, from OR U is more severe than that of OR C , even though the difference between OR* and OR C seems negligible for practical purposes.
The situation with hazard ratios is more complex. Because of the nature of the mixture (confounded) distribution present, unlike HR U , neither HR C nor HR fc is constant over time, violating the assumption of proportional hazards. An investigator using the proportional hazards model with such a data set will estimate the hazard ratio as some "average" of the hazard ratio from time zero to time t. That is, we are assuming that the investigators who actually approach such data regularly assume that the hazard ratio is roughly constant across time. This seems to be a common practice. Therefore, one may be interested in the population average HR C over time interval (0, t), i.e., (9) Then, with the fc-years approach, the average HR^ over time interval {k, t),
would have been of interest, which is the same as 
FIGURE 2. Comparison of odds ratios (ORs). 100
Inspection of h Oc (t) and h lc (f) makes clear that, as time approaches infinity, they approach h Ou (t) and h l u {i), respectively (see the Appendix). In turn, this implies that as time approaches infinity, HR C approaches HR U and hence provides an unbiased estimate of the true effect of exposure. However, over the time interval (0, + 00 ), there is no guarantee that HR C approaches HR M monotonically. On the contrary, h x c (t) may approach /i, u (t) proportionately more rapidly than h 0 c (t) approaches h o , u (f). Thus, there may be time intervals where UR c (t) <HR c (0) < HR U . That is, the observed hazard ratio may move away from its true value before moving toward it.
Analogously, it can also be shown that for any evaluation time t, as fi D approaches infinity, HR C approaches HR U , which implies that the fc-years approach should work for large (3 D . However, the size of P D is an issue. For example, using the example parameter set herein, even if $ D is as large as 5, implying a hazard ratio of over 148 between diseased and nondiseased groups, HR c (f) is smaller than HR C (?) when /3 D is 4, over the interval from t -0-14. In this interval, HR U is far greater. This implies that, for some situations with realistic ks, j3 D may never be large enough to result in a practical reduction in bias. Furthermore, a large j3 D does not necessarily produce a monotonic approach of HR C to HR U as time approaches infinity.
In view of figure 3, with the same specifications of the parameters with j3 o = 4, HR C (or HR fc ) is seen to underestimate the HR U , if it is evaluated at any time less than 100 years. It approaches HR U as time approaches infinity. However, over the time interval from 0 to 8 years, HR C steadily decreases. Suppose that a study were conducted with a total length of follow-up of 16 years, then HR*. must be less than HR C for any k less than 8. It follows that the average hazard ratio over time interval {k, t) may worsen the bias even under the fairly realistic situation of this example. This 
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shows that eliminating subjects who die during the first k years 1) does not necessarily reduce the bias in the estimated effect of exposure, 2) can increase the bias, and 3) is only guaranteed to reduce the bias as k approaches infinity.
To see whether this holds under different sets of parameters, we calculated the effect sizes under varying magnitudes of /3 D (= 3, 4, 5) . The other parameters are fixed at the values discussed thus far under /3 O = 4. The results are tabulated across several selected follow-up times t in table 1. As can be seen in that table, the improvement of bias by means of "kyears" exclusion seems to be negligible for all three types of effect sizes. Finally, these results, regarding the risk ratio, odds ratio, and hazard ratio, can be generalized for continuous risk factors, since if the it-years approach does not necessarily work for any two points in the domain of a continuous risk factor, then it does not necessarily work for the whole domain of the risk factor.
DISCUSSION
In the preceding section it was shown that, when confounding due to preexisting disease is present, excluding subjects who die in the first few years of follow-up does not necessarily reduce the bias due to confounding. However, we have not systematically varied the parameters to survey the effect of "fc-years" exclusion, since there is obviously an infinite number of choices. Even restricting the parameter space is rather difficult, as results will depend on the distributions of the risk factor, the proportions of diseased and nondiseased people at each level of the risk factor, the parametric form of the survival distribution, and the effects on the hazard rate of the varying levels of the risk factor and of the disease. In this context, simulation studies would certainly help to clarify further the effect of the "fc-years" exclusion under various situations, especially considering real distributions of variables such as body mass index and survival times. Asking the question, "What are the effects of "kyears" exclusion likely to be under a wide range of plausible models?," Allison and colleagues conducted such a simulation study (D. B. Allison et al., Obesity Research Center, St. Luke's/Roosevelt Hospital, Columbia University College of Physicians and Surgeons, unpublished manuscript). In brief, the results showed that the "&-years" exclusion had a trivial magnitude of effects on reduction of bias and sometimes increased bias. This was true regardless of which popular data analysis technique was considered. This result parallels the conclusion of this paper, which has addressed the question, "Is it necessarily true that the "it-years" exclusion reduces the confounding due to the preexisting diseases as other authors have indicated it should?" The answer and conclusion under this analytic study are no. Of course, as previously stated, there may be some circumstances under which such exclusion does reduce bias. In this regard, one may question the assumption made throughout the derivations that the survival distribution is exponential, especially because the supposedly high mortality associated with the occult diseases may not continue on time. However, this assumption seems justifiable on two grounds. First, advocates of excluding early deaths have not specified any particular set of circumstances or any particular distribution under which this technique should be used. Moreover, since we are dealing with occult disease, by definition, we do not know exactly what the effects of the occult disease across time are. Therefore, it is unwise to rely on a statistical technique whose utility depends heavily on the situation, since it seems that we do not know a priori what the nature of the situation we are dealing with is. Second, the exponential distribution is equivalent to a Weibull distribution where T is transformed to V and y is any constant (30) . The Weibull distribution is a logical choice, because it has been shown to characterize the survival distribution of much of the adult human lifespan (31, 32) . Moreover, the Weibull distribution is the limiting case of the minimum of a large number of independent nonnegative events and would, therefore, be theoretically expected to characterize death that can result from multiple (semi)independent causes (7).
It must be acknowledged that we have greatly simplified the exposure-mortality situation in several ways. First, we have treated preexisting, occult disease as a confounder, whereas it might be viewed also as an intermediate variable, since part of an effect of exposure on mortality might accrue through disease occurrence (If this is the case, any attempt to correct for its "confounding effect" would be inappropriate regardless of the method used.) However, since the role of occult disease has been specified as a "confounder" in the "fc-years" approach, we assessed its performance under the same assumption. Second, we have assumed that the number of subjects with disease is fixed at the start of follow-up, and only decreases thereafter as diseased people die. More realistically, some subjects might develop disease during follow-up. The occurrence of the occult disease during the course of study may occur in three ways: 1) the occurrence may be unrelated to the risk factor; 2) the risk factor may be causally related to the probability of occurrence; and 3) there may be a relation between the risk factor and the probability of occurrence due to the common influence of a third variable, which may be unobservable. In the first case, the occult disease would not be a confounder, since it is unrelated to the independent variable. In the second case, the occult disease would be a mediating variable, not a confounder. In the third case, confounding would be present and the exact nature of the biases that can be introduced and methods for dealing with these biases might vary. Third, we have assumed that exposure is determined at the start of follow-up, whereas a more detailed model might have it measured and change during the course of follow-up, perhaps due in part to the occurrence of disease. However, our results do show that, even in the simplified situation, the k-years approach does not necessarily reduce confounding.
It is possible that excluding subjects who die early can reduce confounding under some circumstances. Therefore, an interesting question is what the effects of such exclusions have been in real data sets. Because this technique has been widely utilized in the obesity field, we draw on that area for examples. A recent meta-analysis by Troiano et al. (33) compared the association between body mass index (weight (kg)/ height (m) 2 ), a measure of relative weight, before and after exclusions related to the disease. Troiano et al. (33) states "Failure to exclude persons with disease was not associated with a rise in mortality at low BMI [body mass index] with either short or long term follow-up" (33, p. 71). The meta-analysis by Troiano et al. (33) grouped three forms of "disease exclusion" together; excluding early deaths, excluding subjects with disease based on examination results, and excluding subjects with self-reported disease at intake. Thus, the effects of excluding early deaths could not be independently assessed. However, a number of individual studies have examined the effects of excluding early deaths (e.g., [34] [35] [36] [37] [38] , and results do not seem to show any consistent effect of such exclusions. Thus, at least in the area of obesity, the evidence seems to suggest that either 1) there is no confounding due to preexisting disease or 2) excluding early deaths is an ineffective method of reducing such confounding if it does exist.
The implication of our findings is that eliminating subjects who die early is not a desirable analytic strategy for dealing with occult disease because it cannot be counted upon to accomplish its goal and can exacerbate existing biases (this may be related to Gurland and Sethuraman's demonstration (39) that pooling increasing failure rate distributions may result in a decreasing failure rate distribution). Moreover, such exclusions will lower statistical power, a commodity most investigators find too dear to waste.
Given that excluding early deaths is not a strategy that can be relied upon to reduce confounding due to preexisting disease, what alternatives are available for this situation? Clearly the ideal strategy is to measure disease more thoroughly at baseline so that it can be properly taken into account. However, it must be acknowledged that this is easier said than done. A second possibility is to examine separate causes of death using competing risk models (e.g., 7). Evaluating the association of the putative risk factor with causes of death that are theoretically thought to be a function of the risk factor (e.g., heart disease) versus causes that are not thought to be functions of the risk factor (e.g., tuberculosis) may yield insights. However, one must be cautious not to be too presumptuous about claims of biologic plausibility as almost any phenomenon can be made biologically plausible by a sufficiently creative mind (40) . Third, in contrast to excluding subjects who die early which discards information, measuring the risk factor at multiple time points throughout the interval from 0 to t adds new information to the analysis. This information can be incorporated into models with time-dependent covariates (e.g., 7), which may allow one to begin untangling the effects of the putative risk factor on mortality versus the effects of disease on the putative risk factor. As far as inference about the risk ratio and odds ratio with fixed or time-varying covariates is concerned, the generalized estimating equations (41) might prove useful.
